What class is the CELLIGENICS ENABLING CELLULAR THERAPEUTICS trademark registered in?

The CELLIGENICS ENABLING CELLULAR THERAPEUTICS trademark is registered in Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

What is the serial number for CELLIGENICS ENABLING CELLULAR THERAPEUTICS?

The USPTO serial number for CELLIGENICS ENABLING CELLULAR THERAPEUTICS is 79269809.

What is the registration number for CELLIGENICS ENABLING CELLULAR THERAPEUTICS?

CELLIGENICS ENABLING CELLULAR THERAPEUTICS is registered under USPTO registration number 6150027.

CEL

USPTO Trademark Record

REGISTERED

CELLIGENICS ENABLING CELLULAR THERAPEUTICS

SN 79269809·Reg 6150027·Filed Jun 17, 2019

Owner Celligenics Pte. Ltd.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

CELLIGENICS ENABLING CELLULAR THERAPEUTICS (Serial No. 79269809), Registration No. 6150027, is a registered US trademark filed on Jun 17, 2019 by Celligenics Pte. Ltd.. This trademark covers Class 042 (Scientific, technology & SaaS services), Class 044 (Medical, veterinary & beauty care services).

renewal grace 6y period: March 15, 2027165 days remaining

Mark Intelligence

CELLIGENICS ENABLING CELLULAR THERAPEUTICS (Reg. #6150027) is a registered US trademark that has been protecting its owner, Celligenics Pte. Ltd., since 2019. The mark covers Class 042 (Scientific, technology & SaaS services) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 3 opposition proceedings during prosecution.

FILED

Jun 17, 2019

SERIAL

79269809

REG#

6150027

REGISTERED

Sep 15, 2020

Owner

Applicant

Celligenics Pte. Ltd.

Entity

LLC

Address

25 North Bridge Road,, #07-00, 25 North Bridge Singapore 179104

Country

Attorney

NameDavid J. Byer

Law firm

David J. Byer K&L Gates LLP

Address

One Lincoln Street, Boston, MA 02111, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJun 17, 2019

Serial Number79269809

Registration No.6150027

Registration DateSep 15, 2020

Status DateSep 15, 2020

Published for OppositionJun 30, 2020

Mark TypeDesign with words

Status DescriptionLive and registered

Filing Signals

FILED

2019

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

30 events

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Sep 15, 2025

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Mar 12, 2022

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Jul 04, 2021

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jan 04, 2021

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jan 04, 2021

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Dec 15, 2020

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Sep 15, 2020

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Jun 30, 2020

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 30, 2020

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Jun 26, 2020

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 10, 2020

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Jun 10, 2020

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Jun 10, 2020

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

EXAMINERS AMENDMENT -WRITTEN

May 26, 2020

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 26, 2020

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 26, 2020

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 26, 2020

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 26, 2020

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 01, 2020

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 01, 2020

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 01, 2020

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Nov 22, 2019

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Nov 05, 2019

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Nov 05, 2019

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

APPLICATION FILING RECEIPT MAILED

Oct 24, 2019

APPLICATION FILING RECEIPT MAILED

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Oct 21, 2019

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Oct 20, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

ASSIGNED TO EXAMINER

Oct 20, 2019

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Oct 20, 2019

NON-FINAL ACTION WRITTEN

SN ASSIGNED FOR SECT 66A APPL FROM IB

Oct 17, 2019

SN ASSIGNED FOR SECT 66A APPL FROM IB

CELLIGENICS ENABLING CELLULAR THERAPEUTICS

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Celligenics Pte. Ltd.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by David J. Byer

Resources

Company